𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transient Axonal Injury in the Absence of Demyelination: A Correlate of Clinical Disease in Acute Experimental Autoimmune Encephalomyelitis

✍ Scribed by Fahmy Aboul-Enein; Peter Weiser; Romana Höftberger; Hans Lassmann; Monika Bradl

Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
557 KB
Volume
111
Category
Article
ISSN
0001-6322

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Validation of a novel biomarker for acut
Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis
✍ Melissa M. Gresle; Gerry Shaw; Bevyn Jarrott; Estella N. Alexandrou; Anna Friedh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB

## Abstract In multiple sclerosis, inflammatory axonal injury is a key pathological mechanism responsible for the development of progressive neurological dysfunction. The injured axon represents a therapeutic target in this disease; however, therapeutic trials of neuroprotective candidates will ini

Neurophysiological changes in demyelinat
Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat
✍ Jude M. Taylor; John D. Pollard 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

## Abstract Myelin‐sensitized T‐ and B‐cells (lymph node cells) induced experimental autoimmune neuritis (EAN) in Lewis rats after passive transfer to naive recipients. After 6 days, all recipient rats developed tail paresis that progressed to limb paresis within 12–72 h. Progressive nerve conducti

Decreased CNS inflammation and absence o
Decreased CNS inflammation and absence of clinical exacerbation of disease after six months oral administration of bovine myelin in diseased SJL/J mice with chronic relapsing experimental autoimmune encephalomyelitis
✍ A.M. Al-Sabbagh; E.P. Goad; H.L. Weiner; P.A. Nelson 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

Murine chronic relapsing experimental autoimmune encephalomyelitis (CR-EAE) is a model of inflammatory demyelinating disease of the central nervous system (CNS) with similarity to multiple sclerosis (MS) in humans. Mice with confirmed neurologic deficits from CR-EAE were treated by oral administrati